THERAPY DUAL 8 CARDIAC ABLATION SYSTEM,THERAM 8MM THERMISTER ABLATION CATHETER SAFIRE TX ABLATION CATHETER

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

FDA Premarket Approval P040042

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the therapy dual 8 cardiac ablation system. The device is indicated for the treatment of typical atrial flutter.

DeviceTHERAPY DUAL 8 CARDIAC ABLATION SYSTEM,THERAM 8MM THERMISTER ABLATION CATHETER SAFIRE TX ABLATION CATHETER
Classification NameCatheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Generic NameCatheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
ApplicantIRVINE BIOMEDICAL,INC.(IBI)
Date Received2004-10-04
Decision Date2005-11-18
Notice Date2005-11-28
PMAP040042
SupplementS
Product CodeOAD
Docket Number05M-0476
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address IRVINE BIOMEDICAL,INC.(IBI) 2375 Morse Ave. irvine, CA 92614
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040042Original Filing
S054 2022-11-14 30-day Notice
S053
S052 2022-10-19 Normal 180 Day Track No User Fee
S051 2021-09-14 30-day Notice
S050 2021-04-13 30-day Notice
S049 2021-02-25 30-day Notice
S048 2021-01-13 Real-time Process
S047 2020-09-18 30-day Notice
S046
S045 2020-02-20 Real-time Process
S044 2020-02-04 30-day Notice
S043 2019-07-29 30-day Notice
S042 2019-03-15 30-day Notice
S041 2018-12-12 Special (immediate Track)
S040 2018-02-05 30-day Notice
S039
S038
S037 2017-05-04 30-day Notice
S036 2016-08-12 30-day Notice
S035 2016-05-27 30-day Notice
S034 2016-02-19 30-day Notice
S033 2015-11-20 Real-time Process
S032 2015-09-23 30-day Notice
S031 2015-08-21 Normal 180 Day Track No User Fee
S030 2015-04-20 30-day Notice
S029 2014-11-07 Real-time Process
S028 2014-04-30 Normal 180 Day Track No User Fee
S027 2014-03-03 Real-time Process
S026 2013-11-27 Normal 180 Day Track
S025 2013-08-30 30-day Notice
S024 2011-11-29 135 Review Track For 30-day Notice
S023 2011-10-14 30-day Notice
S022 2011-05-09 30-day Notice
S021 2011-01-18 30-day Notice
S020 2010-11-16 Real-time Process
S019
S018 2010-02-22 30-day Notice
S017 2009-12-14 30-day Notice
S016 2009-07-30 30-day Notice
S015 2009-05-04 30-day Notice
S014 2008-11-10 30-day Notice
S013 2008-09-04 Normal 180 Day Track
S012 2008-05-14 30-day Notice
S011 2007-09-19 30-day Notice
S010 2007-03-16 30-day Notice
S009 2007-03-12 Normal 180 Day Track
S008 2007-02-12 Real-time Process
S007 2006-12-18 135 Review Track For 30-day Notice
S006 2006-09-05 Normal 180 Day Track
S005 2006-08-18 Real-time Process
S004 2006-08-01 Real-time Process
S003 2006-06-02 Real-time Process
S002 2006-05-01 Real-time Process
S001 2005-11-22 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05414734306980 P040042 000
05414734306973 P040042 000
05414734306997 P040042 000
05414734307000 P040042 000
05414734307024 P040042 000
05414734307017 P040042 000
05414734308939 P040042 005
05414734309073 P040042 006
05414734307550 P040042 006
05414734307567 P040042 006
05414734307581 P040042 006
05414734307598 P040042 006
05414734300162 P040042 009
05414734300179 P040042 009
05414734300186 P040042 009
05414734300193 P040042 009
05414734300247 P040042 009
05414734300254 P040042 009
05414734300261 P040042 009
05414734300278 P040042 009
05414734300155 P040042 009

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.